Dr. Chalasani’s research interests include nonalcoholic fatty liver disease, drug hepatotoxicity and drug metabolism, and his clinical interests include acute and chronic liver disease, fatty liver and NASH.
Dr. Chalasani earned his medical degree from Kakatiya Medical College in India and completed both his residency and fellowship at Emory University in Atlanta.
More articles on GI & endoscopy:
White House acknowledges AGA’s microbiome initiatives: 5 key notes
5 most read GI/endoscopy stories: May 9 – May 13
Exact Sciences completes 40k Cologuard tests, but net loss totals $47.5M: 6 key notes on Q1 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
